UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026297
Receipt number R000030201
Scientific Title The verification study for neurocognitive status improvement: A randomized double-blind placebo-controlled trial
Date of disclosure of the study information 2017/02/24
Last modified on 2017/10/16 18:59:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The verification study for neurocognitive status improvement: A randomized double-blind placebo-controlled trial

Acronym

The verification study for neurocognitive status improvement

Scientific Title

The verification study for neurocognitive status improvement: A randomized double-blind placebo-controlled trial

Scientific Title:Acronym

The verification study for neurocognitive status improvement

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effects of improvements in neurocognitive status with the intake of test food

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. Neuropsychological tests (Cognitrax)

Key secondary outcomes

1. Dementia Assessment Sheet in Community-based Integrated Care System (DASC-21)
2. Original questionnaire (Likert scale)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Duration: 12 weeks
Test materials: Sea squirt-derived plasmalogen capsule
Dose: 1 capsule, once a day
Administration: Take 1 capsule per day any time during the day

Interventions/Control_2

Duration: 12 weeks
Test materials: Placebo capsule
Dose: 1 capsule, once a day
Administration: Take 1 capsule per day any time during the day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Healthy Japanese adults who feel memory loss

2. Those who are not dementia and are considered as appropriate for the study by the physician

3. Those who get 24 or more in score of MMSE

4. Those who have lower score in total score of Cognitrax

Key exclusion criteria

1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction

2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases

3. Those who have dementia

4. Those who have depression disorder, ADHD, or etc. such as mental illness

5. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily

6. Currently taking medicines and/or herbal medicines

7. Those who take DHA or/and EPA-containing food in daily

8. Those who are allergic to medicines and/or the test food related products

9. Those who are pregnant, breast-feeding, and plan to become a pregnant

10. Those who had participated another clinical test for three months when you signed the informed consent form for this trial

11. Others considered as inappropriate for the study by the physician

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuo YAMAMOTO

Organization

ORTHOMEDICO Inc.

Division name

R&D Department

Zip code


Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.

TEL

03-3818-0610

Email

kazu@orthomedico.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoko SUZUKI

Organization

ORTHOMEDICO Inc.

Division name

R&D Department

Zip code


Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.

TEL

03-3818-0610

Homepage URL


Email

nao@orthomedico.jp


Sponsor or person

Institute

ORTHOMEDICO Inc.

Institute

Department

Personal name



Funding Source

Organization

NIHON PHARMACEUTICAL CO., LTD.
Sunsho Pharmaceutical Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Seishin-kai Medical Association Inc, Takara Medical Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団 盛心会 タカラクリニック (東京都)
Seishin-kai Medical Association Inc, Takara Medical Clinic (Tokyo)


Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 24 Day

Date of IRB


Anticipated trial start date

2017 Year 02 Month 27 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 24 Day

Last modified on

2017 Year 10 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030201


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name